Search Results for: labeling

OKK Trading To Pay $665,000 Civil Penalty for Violating Federal Lead Paint Ban

June 26, 2009 By The CPSC Leave a Comment

WASHINGTON, D.C. - AS PART OF ITS COMMITMENT TO PROTECTING THE SAFETY OF CHILDREN, THE U.S. CONSUMER PRODUCT SAFETY COMMISSION (CPSC) ANNOUNCED TODAY THAT OKK TRADING, OF COMMERCE, CALIF., HAS AGREED TO PAY A $665,000 CIVIL PENALTY (PDF) FOR FAILING TO COMPLY WITH A 30-YEAR OLD BAN ON LEAD PAINT ON TOYS, AS WELL AS VIOLATING OTHER FEDERAL CHILD … [Read more...]

Hi-Tech Pharmaceuticals Recalls All Lots of Stamina-Rx Dietary Supplement Products

June 17, 2009 By The FDA Leave a Comment

Norcross, GA - Hi-Tech Pharmaceuticals, Inc. ("Hi-Tech"), 6015-B Unity Dr., Norcross, GA 30071, announced today that it is conducting a nationwide voluntary recall of the company's product sold under the name Stamina-Rx. On May 1, 2009, Hi-Tech was notified by the Food and Drug Administration (FDA) that FDA's lab analysis of one lot of Stamina-Rx … [Read more...]

CARDINAL ( 09V148000 )

May 3, 2009 By US Recall News Leave a Comment

Vehicle Make / Model: Model Year(s): CARDINAL / 29W 2004 Manufacturer: FOREST RIVER, INC. Mfr's Report Date: JAN 29, 2009 NHTSA CAMPAIGN ID Number: 09V148000 N/A NHTSA Action Number: N/A Component: EQUIPMENT:OTHER:LABELS Potential Number of Units Affected: … [Read more...]

Mrs. Grissom's Salads Announces Recall Due To Undeclared Anchovies

April 11, 2009 By The FDA Leave a Comment

CONTACT: KENNETH FUNGER 1-800-255-0517 FOR IMMEDIATE RELEASE -- APRIL 9, 2009 -- NASHVILLE, TN -- MRS. GRISSOM&RSQUO;S SALADS IS RECALLING&NBSP;ALL&NBSP;LOTS OF THE FOLLOWING CHEESE PRODUCTS DUE TO&NBSP;UNDECLARED ANCHOVIES:&NBSP; CHEESE PRODUCTS PACKAGED UNDER THE MRS. GRISSOM&RSQUO;S BRAND: PREMIUM CHEESE SPREAD, PACKAGED IN 11 OZ, 24 OZ, 48 OZ … [Read more...]

FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market

April 9, 2009 By The FDA 1 Comment

GENENTECH, THE MANUFACTURER OF THE PSORIASIS DRUG RAPTIVA (EFALIZUMAB), ANNOUNCED THAT IT HAS BEGUN A VOLUNTARY, PHASED WITHDRAWAL OF RAPTIVA FROM THE U.S. MARKET. THE COMPANY IS TAKING THIS ACTION BECAUSE OF A POTENTIAL RISK TO PATIENTS OF DEVELOPING PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML), A RARE, SERIOUS, PROGRESSIVE NEUROLOGIC DISEASE … [Read more...]